Updated Jul 16, 2026
Ryan Michael Lee has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Ryan Michael Lee is identified in SEC filings as being associated with Coherus BioSciences, Inc. as of June 9, 2026. The public record provided does not specify his exact role (e.g., officer, director, or insider) and there is no readily available biography in major reference sources based on the provided context. His precise position, tenure with the company, and other biographical details would require direct filing documents (e.g., Form 4, Form 8-K) or company disclosures to confirm.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | CHRS | Coherus BioSciences, Inc. | A — Grant or award | 30.0K | $0.00 |
Ryan Michael Lee is identified in SEC filings as being associated with Coherus BioSciences, Inc. as of June 9, 2026. The public record provided does not specify his exact role (e.g., officer, director, or insider) and there is no readily available biography in major reference sources based on the provided context. His precise position, tenure with the company, and other biograp…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ryan Michael Lee profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.